Fractional Radio Frequency (RF) Microneedle Device Market Report 2025

The fractional radio frequency (RF) microneedle device market size has grown rapidly in recent years. It will grow from $0.91 billion in 2024 to $1.02 billion in 2025 at a compound annual growth rate (CAGR) of 13%. The growth during the historic period was driven by increasing focus on anti-aging and wrinkle reduction treatments, rising popularity of non-surgical skin tightening procedures, greater availability of advanced dermatology devices across markets, growing influence of social media on cosmetic treatment adoption, and expanding healthcare infrastructure supporting aesthetic dermatology services.

The fractional radio frequency (RF) microneedle device market size is expected to see rapid growth in the next few years. It will grow to $1.65 billion in 2029 at a compound annual growth rate (CAGR) of 12.6%. The growth during the forecast period is expected to be supported by higher investment in research and development of advanced RF microneedle devices, growing demand for personalized and combination aesthetic treatments, wider adoption of minimally invasive procedures in emerging economies, technological innovations enhancing treatment precision and safety, and the increasing number of dermatology clinics and medical spas. Key trends anticipated in the forecast period include development of portable and user-friendly RF microneedle devices, combination therapies integrating RF microneedling with platelet-rich plasma (PRP) and laser treatments, customizable treatment settings for different skin types, enhanced safety features such as real-time monitoring and insulated needles, and AI-driven treatment protocols for improved outcomes.

The fractional radio frequency (RF) microneedle device market is expected to grow due to rising demand for minimally invasive cosmetic procedures in the coming years. These procedures improve appearance through methods such as injections, lasers, or small incisions, offering minimal downtime and lower risks compared to traditional surgery. The preference for treatments with shorter recovery periods is increasing, as patients want to return to their daily routines quickly. Fractional RF microneedle devices provide safe, precise, and reliable results by using insulated or adjustable-depth needles that target specific skin layers. For example, in September 2023, the American Society of Plastic Surgeons, a US-based nonprofit led by surgeons, reported that 23.7 million minimally invasive cosmetic procedures were performed in the United States in 2022. This marked a rise compared to previous years, with neuromodulator injections alone accounting for 8,736,591 procedures. This trend is thus driving growth in the fractional RF microneedle device market.

Leading companies in the fractional RF microneedle device market are developing delivery systems with depth intelligence technology to provide precise, safe, and consistent treatments. These systems allow accurate control of radiofrequency energy at targeted skin layers, ensuring even treatment, reducing tissue damage, and improving safety and effectiveness. For instance, in February 2023, Candela, a US-based medical aesthetics firm, introduced the Profound Matrix System, a fractional RF microneedle device. It includes the Matrix Pro applicator featuring depth intelligence technology, real-time impedance feedback, and supports three user-selectable depth and energy settings in a single insertion. This system enables practitioners to tailor treatments to individual patient needs, improving results in skin tightening, wrinkle reduction, and overall facial rejuvenation.

In July 2023, ExoCoBio, a South Korea-based company specializing in exosome-based regenerative aesthetic solutions, acquired a majority stake in BENEV Company Inc. for an undisclosed sum. This acquisition allows ExoCoBio to combine BENEV’s fractional RF microneedle devices with its regenerative products based on exosomes, enhancing treatment effectiveness. BENEV Company Inc. is a US-based medical aesthetics firm focused on RF microneedling systems.

Major players in the fractional radio frequency (RF) microneedle device market are Hologic Inc., InMode Ltd., Lumenis Be Ltd., Candela Medical Inc., Cutera Inc., Lutronic Corporation, Venus Concept Inc., Dermatrix Inc., Cartessa Aesthetics LLC, Beijing Nubway Science & Technology Co. Ltd., Jeisys Medical Inc., WONTECH Co. Ltd., EndyMed Medical Ltd., Deka Medical, Agnes Medical Co. Ltd., Dermatude B.V., Ilooda Co. Ltd., Viol Co. Ltd., Aesthetics Biomedical Inc., and Xi’an Prima Beauty Equipment Co. Ltd.

North America was the largest region in the fractional radio frequency (RF) microneedle device market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in fractional radio frequency (RF) microneedle device report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the fractional radio frequency (RF) microneedle device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

A fractional radio frequency (RF) microneedle device is a medical tool that combines fine needles with radiofrequency energy to address skin concerns such as wrinkles, scars, and laxity. It stimulates collagen production, provides safe and targeted results with minimal downtime, and meets the growing demand for non-surgical aesthetic treatments. The device also enhances patient satisfaction by offering effective and customizable skin rejuvenation solutions.

The primary types in the fractional radio frequency (RF) microneedle device market are single-needle devices and multi-needle devices. Single-needle devices utilize a single fine needle to deliver radiofrequency energy into targeted layers of the skin. Applications include skin rejuvenation, acne scar treatment, wrinkle reduction, hyperpigmentation, and related treatments. End users include hospitals, dermatology clinics, aesthetic centers, and other healthcare facilities.

The fractional radio frequency (RF) microneedle device market research report is one of a series of new reports that provides fractional radio frequency (RF) microneedle device market statistics, including fractional radio frequency (RF) microneedle device industry global market size, regional shares, competitors with a fractional radio frequency (RF) microneedle device market share, detailed fractional radio frequency (RF) microneedle device market segments, market trends and opportunities, and any further data you may need to thrive in the fractional radio frequency (RF) microneedle device industry. The fractional radio frequency (RF) microneedle device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The fractional radio frequency (RF) microneedle device market consists of sales of RF microneedling systems, disposable microneedle cartridges, handpieces, and treatment accessories. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.